However, the possible ascertainment bias towards cases with epilepsy in the SYN1 literature means that we should not yet conclude that anti-seizure medication should be commenced prior to the presentation of seizures as it is likely that a significant proportion of carriers would not benefit from it. Here, SYN1 is linked to epilepsy.